Inhibitors of human immunodeficiency virus replication

US9034882B2 · kind B2 · utility

Assignee

• Bristol-Myers Squibb Company · US

Inventors

• Annapurna Pendri · South Glastonbury, US
• David R. Langley · Meriden, US
• Samuel Gerritz · Guilford, US
• Guo Li · Chengdu, CN
• Weixu Zhai · Middletown, US
• Stanley D'Andrea · Middletown, US
• Manoj Patel · Berlin, US
• B. Narasimhulu Naidu · Durham, US
• Kevin Peese · Haddam, US
• Zhongyu Wang · Nanjing, CN

Key dates

• Filing date: Mar 1, 2013
• Grant date: May 19, 2015
• Expiry date: Apr 27, 2033

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D519/00
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.